Open Access iconOpen Access

ARTICLE

crossmark

The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway

SHUIZHONG CEN1,#, XIAOJIE PENG2,#, JIANWEN DENG3,#, HAIYUN JIN4, ZHINAN DENG5, XIAOHUA LIN3, DI ZHU3, MING JIN6, YANWEN ZHU3, PUSHENG ZHANG3, YUNFENG LUO3, HONGYAN HUANG3,*

1 Department of Spinal Surgery, Orthopedic Medical Center, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China
2 Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
3 Department of Breast Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China
4 Department of Gynecology and Obstetrics, Southern Hospital Taihe Branch, Southern Medical University, Guangzhou, 510540, China
5 Department of Clinical Medicine, Nanshan Class, Guangzhou Medical University, Guangzhou, 511436, China
6 Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, 518110, China

* Corresponding Author: HONGYAN HUANG. Email: email
# These authors provided equal contribution to this work

Oncology Research 2023, 31(3), 375-388. https://doi.org/10.32604/or.2023.028256

Abstract

Triple-negative breast cancer (TNBC) is characterized by fast growth, high metastasis, high invasion, and a lack of therapeutic targets. Mitosis and metastasis of TNBC cells are two important biological behaviors in TNBC malignant progression. It is well known that the long noncoding RNA AFAP1-AS1 plays a crucial role in various tumors, but whether AFAP1-AS1 is involved in the mitosis of TNBC cells remains unknown. In this study, we investigated the functional mechanism of AFAP1-AS1 in targeting Polo-like Kinase 1 (PLK1) activation and participating in mitosis of TNBC cells. We detected the expression of AFAP1-AS1 in the TNBC patient cohort and primary cells by in situ hybridization (ISH), northern blot, fluorescent in situ hybridization (FISH) and cell nucleus/cytoplasm RNA fraction isolation. High AFAP1-AS1 expression was negatively correlated with overall survival (OS), disease-free survival (DFS), metastasis-free survival (MFS) and recurrence-free survival (RFS) in TNBC patients. We explored the function of AFAP1-AS1 by transwell, apoptosis, immunofluorescence (IF) and patient-derived xenograft (PDX) models in vitro and in vivo. We found that AFAP1-AS1 promoted TNBC primary cell survival by inhibiting mitotic catastrophe and increased TNBC primary cell growth, migration and invasion. Mechanistically, AFAP1-AS1 activated phosphorylation of the mitosis-associated kinase PLK1 protein. Elevated levels of AFAP1-AS1 in TNBC primary cells increased PLK1 pathway downstream gene expression, such as CDC25C, CDK1, BUB1 and TTK. More importantly, AFAP1-AS1 increased lung metastases in a mouse metastasis model. Taken together, AFAP1-AS1 functions as an oncogene that activates the PLK1 signaling pathway. AFAP1-AS1 could be used as a potential prognostic marker and therapeutic target for TNBC.

Graphical Abstract

The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway

Keywords


Cite This Article

APA Style
CEN, S., PENG, X., DENG, J., JIN, H., DENG, Z. et al. (2023). The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway. Oncology Research, 31(3), 375-388. https://doi.org/10.32604/or.2023.028256
Vancouver Style
CEN S, PENG X, DENG J, JIN H, DENG Z, LIN X, et al. The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway. Oncol Res. 2023;31(3):375-388 https://doi.org/10.32604/or.2023.028256
IEEE Style
S. CEN et al., "The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway," Oncol. Res., vol. 31, no. 3, pp. 375-388. 2023. https://doi.org/10.32604/or.2023.028256



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 2858

    View

  • 879

    Download

  • 1

    Like

Share Link